Munich Re’s global medical team recently collaborated on a wide-ranging thought leadership project intended to help life insurers better understand and navigate the most prevalent emerging medical trends and risks across five critical topics: AI in Healthcare, Improving Cancer Outcomes, Prevention, Obesity, and Climate Change. The first chapter, AI in Healthcare, is now live. It covers how AI will enhance healthcare through advancements in disease prevention, diagnosis, and treatment, with profound impacts on life and health insurance. These advancements in AI technology promise to improve mortality and morbidity, reshaping the future of life and health insurance.
Key Insights:
- Improved Mortality & Morbidity: AI will drive improvements in mortality and morbidity for many medical conditions through better prevention, earlier diagnoses, and individualized therapies. This will expand insurability.
- Disease Prevention: Major progress in disease prevention is anticipated, offering opportunities for insurers to enrich insured-lives portfolios and innovate product offerings.
- Underwriting & Risk Selection: The analysis of vast datasets from electronic health records (EHRs), imaging, and other biomedical sources will provide a rich resource for risk selection, enabling more accurate and sophisticated underwriting.
- Critical Illness: Critical illness products will need constant updating as earlier diagnosis and new disease classifications emerge. Antiselection may become problematic, as may overdiagnosis.
- Complex Claims Management: As disease understanding shifts towards genetic and molecular diagnoses, claims management will become more complex. Insurers will need cutting-edge medical expertise for claims analysis and dispute resolution.
Bookmark our Life Science Report landing page to access all chapters and to sign up for our newsletter so you are alerted when the subsequent chapters on Improving Cancer Outcomes, Prevention, Obesity, and Climate Change are released.
Sponsored by ITL Partner: Munich Re
